Cutting Edge: The UNC93B1 Tyrosine-Based Motif Regulates Trafficking and TLR Responses via Separate Mechanisms
Karin Pelka(Broad Institute), Eicke Latz(German Rheumatism Research Centre), Rainer Stahl(University of Bonn), Jonathan L. Schmid‐Burgk(University Hospital Bonn), Stefan Höning(University of Cologne), Jean‐Laurent Casanova(Howard Hughes Medical Institute), Jan-Hendrik Spille(University of Illinois Chicago), Sudhir Agrawal(Idera Pharmaceuticals (United States)), Kshiti Phulphagar(University of Bonn), Tobias Schmidt(SIB Swiss Institute of Bioinformatics), Ann Marshak‐Rothstein(UMass Memorial Health Care), Ekambar R. Kandimalla(Idera Pharmaceuticals (United States)), Jana Zimmermann(University of Cologne), Veit Hornung(University of Massachusetts Chan Medical School)
Cited by 36
Related Papers
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Mediator and RNA polymerase II clusters associate in transcription-dependent condensates
|Science|2018|1.5k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Toll-like receptors in systemic autoimmune disease
|Nature reviews. Immunology|2006|1.1k